Picture of Tempus AI logo

TEM — Tempus AI News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI

BRIEF-Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI

- Biovica International AB BIOVICb.ST:

  • REFOCUSES US COMMERCIAL STRATEGY AND TERMINATES AGREEMENT WITH TEMPUS AI

  • COLLABORATION WITH TEMPUS DID NOT RESULT IN COMMERCIAL LAUNCH OR REVENUE

  • TERMINATION DOES NOT AFFECT SAN DIEGO LAB, US CLINICAL ACTIVITIES, OR PHARMA SERVICES

Source text: ID:nMFN9S9B53

Further company coverage: [BIOVICb.ST]


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Tempus AI

See all news